#1
#1 out of 1
science5h ago
Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March
- Defence Therapeutics will showcase its Accum platform at BIO-Europe Spring in Lisbon, March 23–26, to focus on strategic partnerships.
- At DCAT Week in New York, Defence will advance its biomanufacturing capabilities and engage contract partners for Accum production.
- Defence will expand its U.S. presence with the South Florida Life Sciences Showcase and FII PRIORITY Miami in late March for investor outreach.
- Defence recently joined DCAT and BioFlorida, reinforcing its commitment to controlled production and Florida's life sciences ecosystem.
- CEO Sébastien Plouffe said Accum could significantly enhance intracellular delivery and positioning as a game-changing ADC technology.
- Defence aims to advance strategic partnerships and strengthen its global network through March events.
- The press release cites Accum as a differentiated intracellular delivery technology for ADCs, RDCs, and other complex biologics.
- Defence states Accum can enable more efficient intracellular delivery at lower doses to improve safety.
- Defence will seek meetings with biopharma partners during BIO-Europe Spring to discuss Accum partnerships.
Vote 0